↓ Skip to main content

Toll-like receptor 9 activation with CpG oligodeoxynucleotides for asthma therapy.

Overview of attention for article published in Drug News and Perspectives, January 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#24 of 279)
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

patent
8 patents

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Toll-like receptor 9 activation with CpG oligodeoxynucleotides for asthma therapy.
Published in
Drug News and Perspectives, January 2008
DOI 10.1358/dnp.2008.21.8.1272133
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 2 20%
Researcher 2 20%
Professor > Associate Professor 1 10%
Other 1 10%
Unknown 4 40%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 3 30%
Pharmacology, Toxicology and Pharmaceutical Science 2 20%
Agricultural and Biological Sciences 1 10%
Unknown 4 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 October 2018.
All research outputs
#5,037,948
of 33,982,974 outputs
Outputs from Drug News and Perspectives
#24
of 279 outputs
Outputs of similar age
#22,731
of 225,362 outputs
Outputs of similar age from Drug News and Perspectives
#5
of 28 outputs
Altmetric has tracked 33,982,974 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 279 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 225,362 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.